"The final DAFFODIL results provide critical insights into the safety and tolerability of DAYBUE in younger pediatric Rett syndrome patients, including effective strategies to mitigate common side ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback